4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0001209191-23-052622
Director sold 242 shares at $360.00 ($87,120)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bhatia Sangeeta N. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-10-06 | Sale : show line 1 in the form 10b5-1 | −242 | $360.00 | $87,120 | 4,144 | D |
| Open-market sales · 242 sh · avg $360.00 · $87,120 | ||||||
Loading xslF345X05/doc4.xml…